The $51M Bet to Make the Doctor Obsolete
Sponsor: Longevity Investors Conference The Longevity Investors Conference brings together the scientists working at the root of aging, the clinicians translating research into practice, the founders building the next generation of longevity companies, and the investors deciding what gets funded next. The seventh edition takes place from 14 to 17 September 2026 at Le Grand Bellevue in Gstaad, Switzerland. Participation is limited and applications are reviewed individually. Click the link below to apply for LIC 2026. Link: https://www.longevityinvestors.ch/lic-2026 ---------- Guests: Max Marchione Founder & CEO of Superpower, Speaker at Longevity Investors Conference Gstaad 2026 LinkedIn and X: https://www.linkedin.com/in/maxmarchione/, https://x.com/maxmarchione Website: https://superpower.com/ ---------- What if the future of healthcare is not a better hospital, but a system designed to keep you out of one? Phil Newman sits down with Max Marchione, co-founder and CEO of Superpower, to explore his vision for a preventive health platform combining advanced diagnostics, longitudinal health data, wearables, AI and clinicians in one continuous system. Recorded as a Longevity Investors Conference special, the conversation examines why healthcare remains largely reactive and episodic, and what it would take to create an experience that continuously monitors health, connects biological signals and intervenes before problems become disease. Max explains how Superpower uses AI to examine data across blood tests, medical records and wearables, identifying patterns that may be difficult to uncover during a short medical appointment. They also discuss where human clinicians remain essential, particularly when decisions involve prescriptions, hormone therapy or other higher-risk interventions. The conversation explores the limitations of conventional blood-test reference ranges, the growing interest in peptides, including GLP-1 therapies and the controversial BPC-157, and why promising anecdotes must still be tested through rigorous clinical research. They also discuss Superpower’s direct-to-consumer and employer-funded models, the observational health dataset the company is building, the regulatory debate around right-to-try laws and Max’s much larger ambition to help create healthier cities. In this episode, you’ll learn: Why Max believes healthcare will become more preventive, continuous and software-driven.How AI could connect patterns across blood tests, wearables, medical records and reported symptoms.Why being within a “normal” blood-test range does not necessarily mean a result is optimal for long-term health. Where AI may support medical reasoning and why physicians remain responsible for important treatment decisions. How Superpower aims to make elements of high-cost concierge medicine accessible at a lower price. Why employers and insurers may have a financial incentive to invest in preventive healthcare. Why peptides could become an increasingly important medical modality, and where the evidence remains uncertain. How repeated testing, treatment data and symptom tracking could contribute to longitudinal observational research. What right-to-try laws could mean for medical autonomy, regulation and clinical innovation. What a health-first city might look like and why infrastructure, community and culture matter as much as policy. If you want to understand how AI, continuous diagnostics and longitudinal data could shift healthcare from episodic treatment toward proactive health management, this episode connects an ambitious technological vision with the clinical, commercial and regulatory realities of building a new healthcare system. Subscribe for weekly episodes exploring longevity science, preventive medicine and the systems shaping how we live longer and better. ---------- Host: Phil Newman: https://qrco.de/bgXpNY